Chroma Technology Corp Company Profile

22:02 EST 17th November 2017 | BioPortfolio

Chroma Technology Corp. is a manufacturer of interference filters for the ultra-violet, visible and near-infrared portions of the spectrum, including bandpass, multiple bandpass, and long and short pass filters, as well as beamsplitters, dichroic mirrors and laser rejection filters. We specialize in precision spectral control, including extra high signal-to-noise ratio filters and those with rapid cut-on and cut-off profiles. The manufacturing process involves precisely depositing, in a vacuum, extremely thin layers of two or more materials on a glass or similarly transparent substrate.
Chroma was organized by several talented individuals who wanted to create a working environment entirely different from the typical corporate structure. Founded in Brattleboro, Vermont, in May 1991, Chroma quickly established itself as a leader in filter designs. From its inception, Chroma has worked closely with the community of molecular and cell biologists worldwide to develop the best possible solutions to applications requiring fluorescence filters. As an employee owned Company, it has grown from seven employees with sales of $314,200 in its first year of business, to 54 employees with sales of $12,000,000 in its 10th year of business.

Currently, microscope filter sales represent 66% of total revenues. Chroma is a principal supplier to three of the four major microscope manufacturers and a secondary supplier of the fourth. The remaining 34% of Chroma's business comes from manufacturers in bioscience instrumentation, bio-medical instrumentation, pharmaceutical research, astronomy and laser-based instrumentation. Chroma's filters are distributed worldwide with 34% of its business from international sales.


10 Imtec Lane, PO Box 489
United States of America


Phone: 802-428-2500
Fax: 802-428-2525

News Articles [78 Associated News Articles listed on BioPortfolio]

Chroma Therapeutics’ Deal with GlaxoSmithKline

At the BIA Leadership Summit, Dr Fintan Walton spoke to Ian Nicholson, CEO of Chroma Therapeutics. They discussed: • Chroma’s deal with GSK • the key to Chroma’s novel chemistry platform tech...

Ian Nicholson of Chroma Therapeutics discusses their recent deal with CTI

In this episode of PharmaTelevision News Review, Fintan Walton talks to Ian Nicholson, CEO at Chroma Therapeutics

Twin lampalizumab trials fail to impact area of geographic atrophy

Jeffrey S. HeierNEW ORLEANS — Lampalizumab failed to impact geographic area compared with sham treatment in two identically designed phase 3 studies — Chroma and Spectri, according to a speaker.Gi...

HempTech (HTCO) Merges with Nuvus Corp – NUVUS to Merge the Two Fastest Growing Global Industries - Cannabis & Blockchain Technology

Saint Petersburg, FL, Nov. 02, 2017 (GLOBE NEWSWIRE) -- HempTech Corp. (OTC PINK: HTCO), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytic...

Helix BioPharma Corp. Director Resigns

TORONTO, ONTARIO -- (Marketwired) -- 07/17/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the...

Global DNA and Gene Chip Market Research Report 20112023 [Report Updated: 27102017] Prices from USD $2990

SummaryThe global DNA and Gene Chip market will reach xxx Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define, segment, and project the market on the basis of product type...

GTX Corp Receives Military Contract

LOS ANGELES, CALIFORNIA , Sept. 20, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive ...

GTX Corp Partners with ORBCOMM to Enable GPS SmartSoles on the Verizon Network

LOS ANGELES, CALIFORNIA , Sept. 12, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive te...

PubMed Articles [635 Associated PubMed Articles listed on BioPortfolio]

Technology Games: Using Wittgenstein for Understanding and Evaluating Technology.

In the philosophy of technology after the empirical turn, little attention has been paid to language and its relation to technology. In this programmatic and explorative paper, it is proposed to use t...

Technology Interventions to Manage Food Intake: Where Are We Now?

This review describes the state-of-the-art for dietary assessment using smartphone apps and digital technology and provides an update on the efficacy of technology-mediated interventions for dietary c...

Ability to Resist Temptations of Technology Use: A Qualitative Analysis of Children's Views on Factors Associated with Delay of Gratification.

Excessive technology use among young children remains a public health concern with diverse serious consequences. It is important to find out how children resist the temptation to use technology. Using...

Subjective Technology Adaptivity Predicts Technology Use in Old Age.

To date, not much is known about the psychological and motivational factors underlying technology use in late life. What are the interindividual determinants that lead older adults to invest in using ...

Initial Clinical Experience with a Modulated Holmium Laser Pulse-Moses Technology: Does It Enhance Laser Lithotripsy Efficacy?

The Lumenis(®) High-power Holmium Laser (120H) has a unique modulated pulse mode, Moses™ technology. Moses technology modulates the laser pulse to separate the water (vapor bubble), then deliver th...

Clinical Trials [1100 Associated Clinical Trials listed on BioPortfolio]

Randomized Clinical Trial of Occlusal Sealant

This study assessed long-term impact of tooth Eruption Stages (ES) on sealant retention on occlusal surfaces previously coated with intermediary bonding layer and it determined caries inci...

User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™

The primary aim of this study is to demonstrate the maintenance of healthy peri-stomal skin over a two month period in subjects who use ConvaTec Moldable Technology™ Skin Barriers as par...

Safety and Efficacy of Using GlucoSat Technology For Non-Invasive Glucose Measurement

This study is a prospective, open label, controlled, single center study. 40 patients will be recruited for the study, according to patients’ inflow and meeting eligibility criteria. Pr...

Endoleak Repair Guided by Navigation Technology

The study is aimed at investigating whether repair of endoleak type II can be improved by adding navigation technology. Can this technology increase precision by guiding the needle that pu...

Improving Outcomes Using Technology for Children Who Are DHH

This study evaluates the efficacy of using augmentative and alternative communication (AAC) technology for enhancing language development in children who are deaf or hard of hearing. Half ...

Companies [478 Associated Companies listed on BioPortfolio]

Chroma Technology Corp

Chroma Technology Corp. is a manufacturer of interference filters for the ultra-violet, visible and near-infrared portions of the spectrum, including bandpass, multiple bandpass, and long and short pa...

Chroma Technology Corp.

Chroma Therapeutics Ltd

Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology. Chroma is the first company to system...





More Information about "Chroma Technology Corp" on BioPortfolio

We have published hundreds of Chroma Technology Corp news stories on BioPortfolio along with dozens of Chroma Technology Corp Clinical Trials and PubMed Articles about Chroma Technology Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chroma Technology Corp Companies in our database. You can also find out about relevant Chroma Technology Corp Drugs and Medications on this site too.

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record